1.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

2.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

3.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

4.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

5.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

6.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

7.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

8.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

9.

Alcohol consumption changes during the first COVID-19 lockdown: an online population survey in a convenience sample of French-speaking Belgian residents.

1.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

2.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

3.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

4.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

5.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

6.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

7.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

8.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

9.

Alcohol consumption changes following COVID-19 lockdown among French-speaking Belgian individuals at risk for alcohol use disorder.

1.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

2.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

3.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

4.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

5.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

6.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

7.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

8.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

9.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

1.

Organ donation in Belgium 2011: the highest donation rate ever

2.

Organ donation in Belgium 2011: the highest donation rate ever

3.

Organ donation in Belgium 2011: the highest donation rate ever

4.

Organ donation in Belgium 2011: the highest donation rate ever

5.

Organ donation in Belgium 2011: the highest donation rate ever

6.

Organ donation in Belgium 2011: the highest donation rate ever

7.

Organ donation in Belgium 2011: the highest donation rate ever

8.

Organ donation in Belgium 2011: the highest donation rate ever

9.

Organ donation in Belgium 2011: the highest donation rate ever

1.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

2.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

3.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

4.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

5.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

6.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

7.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

8.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

9.

Psychometric properties of the temperament and character inventory-revised (TCI-R) in a Belgian sample.

1.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

2.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

3.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

4.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

5.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

6.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

7.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

8.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

9.

Evolution of methylisothiazolinone sensitization: A Belgian multicentric study from 2014 to 2019.

1.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

2.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

3.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

4.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

5.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

6.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

7.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

8.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

9.

Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.

1.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

2.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

3.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

4.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

5.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

6.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

7.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

8.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

9.

Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

1.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

2.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

3.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

4.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

5.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

6.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

7.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

8.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

9.

Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.

1.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

2.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

3.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

4.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

5.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

6.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

7.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

8.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium

9.

Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium